The economics for some of these labs is also pretty different from what you'd normally expect. There are numerous semi-private organizations in the defense space ( such as Boston Dynamics ) and similarly in the pharmaceutical space. Which may only produce commercially viable technology after a decade or more. For many of these entities, the funding dynamics are dependent on the overall scope of the problem along with the quality of the team rather than any direct foreseeable economic outcome.